Drug manufacturers whose products are under review by the Ohio Department of Medicaid (ODM) P&T Committee may request the opportunity to present clinical information at the meeting during which their product is reviewed. Any presentation by a drug manufacturer should focus on the relative clinical merits of their drug versus a comparable product. Please note that price should not be discussed with P&T Committee members.
To request a presentation, email speaker contact information along with what product will be presented to the ODM clinical vendor mailbox at PBA_OHMedicaidFFS@changehealthcare.com no later than the Friday before the meeting.*
- Presentations will be limited to a maximum of five minutes, with the Committee chair having the option to extend or limit the time depending upon the situation
- The presenter should provide 12 hard copies of any presentation to the Committee members
*For the Annual UPDL review, which takes place in the 4th Quarter of each year, drug manufacturers should refer to the information available at http://pharmacy.medicaid.ohio.gov to identify when and how they should request to present. This meeting will have an earlier cut-off date, at least four weeks prior to the meeting. Note, when the notice becomes available it will appear at the top of the home page; otherwise, the notice is not yet available.